EGFR Pathway Mutations in Lung Cancer Patient Tumors and Blood
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at tumor tissue samples and blood samples to learn more about DNA changes in patients with lung cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
⁃ DISEASE CHARACTERISTICS:
• Histologically or cytologically confirmed lung cancer
⁃ PATIENT CHARACTERISTICS:
• Not specified
⁃ PRIOR CONCURRENT THERAPY:
• May have received prior EGFR inhibitors
Locations
United States
California
University of California Davis Cancer Center
RECRUITING
Sacramento
Time Frame
Start Date: 2005-05
Estimated Completion Date: 2026-12
Participants
Target number of participants: 800
Treatments
Patients with lung cancer
Collection of archival tumor specimen at the beginning of the study and collection of blood samples at the beginning of the study and then at regular intervals
Related Therapeutic Areas
Sponsors
Leads: University of California, Davis